natgillin/translations-raw huggingface dataset:
- klasse 1a-antiarytmika, (fx quinidin, hydroquinidin, disopyramid) - klasse 3-antiarytmika, (fx amiodaron, sotalol, doftilid, ibutilid) - visse antipsykotika (fx thioridazin, chlorpromazin, levomepromazin, trifluoperazin, 
- class Ia antiarrythmics (e.g. quinidine, hydroquinidine, disopyramide) - class III antiarrythmics (e.g. amiodarone, sotalol, dofetilide, ibutilide) - some antipsychotics (e.g. thioridazine, chlorpromazine, levomepromazine, trifluoperazine,
Actelsar HCT 40 mg/12,5 mg tabletter EU/1/13/817/043 
Actelsar HCT 40 mg/12.5 mg tablets EU/1/13/817/043
Blodtrykssænkningen med Actelsar HCT kan blive mindre ved samtidig brug af medicin mod gigt og lette smerter (non-steroid antiinflammatorisk medicin (NSAID)), f.eks. acetylsalicylsyre eller ibuprofen. 
The effect of Actelsar HCT may be reduced when you take NSAIDs (non steroidal anti-inflammatory medicines, e.g. acetylsalicyl acid or ibuprofen).
- Forsnævring af blodkarrene til den ene eller begge nyrer (nyre-arteriestenose). 
- Renal artery stenosis (narrowing of the blood vessels to one or both kidneys).
Tabellen nedenfor viser de bivirkninger, der forekom hyppigere (p ≤0,05) for telmisartan plus hydrochlorthiazid end for placebo i de kliniske forsøg. 
Adverse reactions reported in all clinical trials and occurring more frequently (p≤0.05) with telmisartan plus hydrochlorothiazide than with placebo are shown below according to system organ class.
Fastdosiskombinationen Actelsar HCT (40 mg telmisartan/12,5 mg hydrochlorthiazid og 80 mg telmisartan/12,5 mg hydrochlorthiazid) er indiceret til voksne, hvis blodtryk ikke kan reguleres tilfredsstillende med telmisartan alene. 
Actelsar HCT fixed dose combination (40 mg telmisartan/12.5 mg hydrochlorothiazide and 80 mg telmisartan/12.5 mg hydrochlorothiazide) is indicated in adults whose blood pressure is not adequately controlled on telmisartan alone.
Artralgi, muskelkramper, smerter i ekstremiteter Det reproduktive system og mammae Ikke almindelig: 
Arthralgia, muscle cramps, pain in limb Reproductive system and breast disorders Uncommon:
Tidligere rapporterede bivirkninger for de enkelte indholdsstoffer kan også være potentielle bivirkninger i forbindelse med Actelsar HCT, selvom de ikke er observeret i kliniske forsøg med dette produkt. 
Adverse reactions previously reported with one of the individual components may be potential adverse reactions with Actelsar HCT, even if not observed in clinical trials with this product.
Actelsar HCT må ikke gives til patienter med svært nedsat leverfunktion. 
Actelsar HCT is not indicated in patients with severe hepatic impairment.
- Medicin, der påvirkes af ændringer i kaliumindholdet i blodet, såsom hjertemedicin (f.eks. digoxin) og medicin til at kontrollere hjerterytmen (f.eks. quinidin, disopyramid, amiodaron, sotalol), medicin, som bruges til psykiske lidelser (f.eks. thioridazin, chlorpromazin, levomepromazin) og andre lægemidler, såsom visse antibiotika (f.eks sparfloxacin, pentamidin) eller visse lægemidler til behandling af allergiske reaktioner (f.eks terfenadin). 
- Medicines that are affected by changes of the blood potassium level such as heart medicines (e.g. digoxin) or medicines to control the rhythm of your heart (e.g. quinidine, disopyramide, amiodarone, sotalol), medicines used for mental disorders (e.g. thioridazine, chlorpromazine, levomepromazine) and other medicines such as certain antibiotics (e.g. sparfloxacine, pentamidine) or certain medicines to treat allergic reactions (e.g. terfenadine).
I randomiserede, kontrollerede forsøg med alt i alt 1471 patienter var den totale rapporterede forekomst af bivirkninger ved brug af telmisartan/hydrochlorothiazid (835 patienter) sammenlignelig med forekomsten for telmisartan alene (636 patienter). 
The overall incidence of adverse reactions reported with telmisartan/hydrochlorothiazide was comparable to those reported with telmisartan alone in randomised controlled trials involving 1,471 patients randomised to receive telmisartan plus hydrochlorothiazide (835) or telmisartan alone (636).
- Overfølsomhed over for de aktive stoffer eller ét eller flere af hjælpestofferne anført i pkt. 
- Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Ikke almindelige (kan forekomme hos op til 1 ud af 100 brugere): 
Uncommon (may affect up to 1 in 100 people):
Al/PVC/PVDC blister: 28, 56, 84, 90 og 98 tabletter Actelsar HCT 80 mg/12,5 mg tabletter 
Al/PVC/PVDC blister: 28, 56, 84, 90 and 98 tablets Actelsar HCT 80 mg/12.5 mg tablets
Actelsar HCT 80 mg/12,5 mg tabletter EU/1/13/817/014 
Actelsar HCT 80 mg/12.5 mg tablets EU/1/13/817/014
Diarré, mundtørhed, flatulens 
Diarrhoea, dry mouth, flatulence
MÆRKNING, DER SKAL ANFØRES PÅ DEN INDRE EMBALLAGE Etiket til HDPE tabletbeholder 
PARTICULARS TO APPEAR ON THE INNER PACKAGING Label for HDPE tablet container
MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE Pap til Al/Al blister 
PARTICULARS TO APPEAR ON THE OUTER PACKAGING Carton for Al/Al blister
Dette baseres på beskeden erfaring hos patienter med let til moderat nedsat nyrefunktion (kreatinin-clearance på 30-60 ml/min, gennemsnit ca. 50 ml/min). 
Based on modest experience in patients with mild to moderate renal impairment (creatinine clearance of 30-60 ml/min, mean about 50 ml/min) no dose adjustment is necessary in patients with decreased renal function.
Behandling i andet og tredje trimester med angiotensin II-receptorantagonister kan medføre humanføtotoksicitet (nedsat nyrefunktion, oligohydramnios, forsinkelse af knogledannelsen i kraniet) og neonataltoksicitet (nyresvigt, hypotension, hyperkaliæmi) (se pkt. 
Exposure to angiotensin II receptor antagonist therapy during the second and third trimesters is known to induce human fetotoxicity (decreased renal function, oligohydramnios, skull ossification retardation) and neonatal toxicity (renal failure, hypotension, hyperkalaemia) (see section 5.3).
Forværring eller aktivering af systemisk lupus erythematosuss1 
Exacerbation or activation of systemic lupus erythematosus1 Metabolism and nutrition disorders Uncommon:
Erektil dysfunktion Almene symptomer og reaktioner på administrationsstedet Ikke almindelig: 
Erectile dysfunction General disorders and administration site conditions Uncommon:
Hvide eller næsten hvide, 6,55 x 13,6 mm ovale og bikonvekse tabletter mærket med "TH" på den ene side. 
White or almost white, 6.55 x 13.6 mm oval-shaped and biconvex tablets marked with “TH” on one side.
I et dobbeltblindt kontrolleret klinisk studie (n=687 patienter evalueret for effekt) hos nonrespondenter i forhold til 80 mg/12,5 mg kombinationen, blev der påvist en øget blodtryktssænkende effekt ved behandling med 80 mg/25 mg kombinationen sammenlignet med fortsat behandling med 80 
In a double-blind controlled clinical trial (n=687 patients evaluated for efficacy) in non-responders to the 80 mg/12.5 mg combination, an incremental blood pressure lowering effect of the 80 mg/25 mg combination compared to continued treatment with the 80 mg/12.5 mg combination of 2.7/1.6 mm Hg
Abdominalsmerter, obstipation, dyspepsi, opkastning, gastrit 
Abdominal pain, constipation, dyspepsia, vomiting, gastritis
Actelsar HCT's udseende og pakningsstørrelse 
What Actelsar HCT looks like and contents of the pack
For Al/PVC/PVDC blister: Må ikke opbevares ved temperaturer over 30ºC. 
For Al/PVC/PVDC blister Do not store above 30ºC.
Kør ikke bil eller motorcykel, og lad være med at cykle eller arbejde med værktøj eller maskiner, hvis du føler dig svimmel eller træt. 
If you feel dizzy or tired, do not drive or operate machinery.
- Actelsar HCT 80 mg/25 mg én gang dagligt er til patienter, hvis blodtryk ikke kan reguleres tilfredsstillende med Actelsar HCT 80 mg/12,5 mg, eller til patienter, som tidligere er blevet stabiliseret med telmisartan eller hydrochlorthiazid hver for sig. 
- Actelsar HCT 80 mg/25 mg may be administered once daily in patients whose blood pressure is not adequately controlled by Actelsar HCT 80 mg/12.5 mg or in patients who have been previously stabilised on telmisartan and hydrochlorothiazide given separately.
- Actelsar HCT 40 mg/12,5 mg én gang dagligt er til patienter, hvis blodtryk ikke kan reguleres tilfredsstillende med telmisartan 40 mg - Actelsar HCT 80 mg/12,5 mg én gang dagligt er til patienter, hvis blodtryk ikke kan reguleres tilfredsstillende med telmisartan 80 mg 
- Actelsar HCT 40 mg/12.5 mg may be administered once daily in patients whose blood pressure is not adequately controlled by telmisartan 40 mg - Actelsar HCT 80 mg/12.5 mg may be administered once daily in patients whose blood pressure is not adequately controlled by telmisartan 80 mg
Der blev ikke fundet statistisk signifikant forskel i det primære sammensatte endepunkt (kardiovaskulær død, ikke-letalt myokardieinfarkt, ikkeletal apopleksi eller hospitalsindlæggelse pga. hjertesvigt) [15,7 % i telmisartangruppen og 17,0 % i placebogruppen med en hazard ratio på 0,92 (95 % CI 0,81-1,05; p = 0,22)]. 
No statistically significant difference in the incidence of the primary composite endpoint (cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, or hospitalization for congestive heart failure) was found [15.7% in the telmisartan and 17.0% in the placebo groups with a hazard ratio of 0.92 (95% CI 0.81-1.05, p=0.22)].
Der er intet, der tyder på, at Actelsar HCT kan reducere eller forhindre diuretika forårsaget hyponatriæmi. 
- Hyponatraemia and hypochloraemic alkalosis There is no evidence that Actelsar HCT would reduce or prevent diuretic-induced hyponatraemia.
Fastdosiskombinationen Actelsar HCT (80 mg telmisartan/25 mg hydrochlorthiazid) er indiceret til voksne, hvis blodtryk ikke kan reguleres tilfredsstillende med Actelsar HCT 80 mg/12,5 mg (80 mg telmisartan/12,5 mg hydrochlorthiazid), eller voksne, som tidligere er blevet stabiliseret med telmisartan og hydrochlorthiazid hver for sig. 
Actelsar HCT fixed dose combination (80 mg telmisartan/25 mg hydrochlorothiazide) is indicated in adults whose blood pressure is not adequately controlled on Actelsar HCT 80 mg/12.5 mg (80 mg telmisartan/12.5 mg hydrochlorothiazide) or adults who have been previously stabilised on telmisartan and hydrochlorothiazide given separately.
Actelsar HCT findes ligeledes med dosisstyrke 40 mg/12,5 mg og 80 mg/ 12,5 mg 
Actelsar HCT is also available at the dose strengths 40 mg/12.5 mg and 80 mg/12.5 mg
Eksem, medikamentelt udslæt, toksisk hududslæt Knogler, led, muskler og bindevæv Sjælden: 
Eczema, drug eruption, toxic skin eruption Musculoskeletal, connective tissue and bone disorders Rare:
Omvendt kan hyperkaliæmi optræde på grund af telmisartans antagonistiske effekt hos Actelsar HCT på angiotensin II (AT1)-receptorerne. 
Conversely, due to the antagonism of the angiotensin II (AT1) receptors by the telmisartan component of Actelsar HCT, hyperkalaemia might occur.
Hvis Actelsar HCT tages mere end 3 måneder henne i graviditeten, kan det forårsage alvorlige fosterskader (se afsnit Graviditet). 
Actelsar HCT is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).
Actelsar HCT bør ikke gives til patienter med kolestase, biliære obstruktive sygdomme eller svær leverinsufficiens (se pkt. 
Actelsar HCT should not be given to patients with cholestasis, biliary obstructive disorders or severe hepatic insufficiency (see section 4.3) since telmisartan is mostly eliminated with the bile.
Actelsar HCT 40 mg/12,5 mg tabletter Actelsar HCT 80 mg/12,5 mg tabletter 
Actelsar HCT 40 mg/12.5 mg tablets Actelsar HCT 80 mg/12.5 mg tablets
Der var ikke evidens for reduktion af kardiovaskulær mortalitet i forhold til placebo (hazard ratio 1,03, CI 0,85-1,24). 
There was no evidence for benefit on cardiovascular mortality (hazard ratio 1.03, 95% CI 0.85-1.24).
Det frarådes at anvende hydrochlorothiazid i ammeperioden. 
The use of hydrochlorothiazide during breast feeding is not recommended.
Nedenstående bivirkninger, der er blevet rapporteret for de to aktive indholdsstoffer, er også mulige bivirkninger for Actelsar HCT, selvom de ikke er set i kliniske studier med dette lægemiddel. 
Adverse reactions reported with one of the individual components may be potential adverse reactions with Actelsar HCT, even if not observed in clinical trials with this product.
Actelsar HCT 40 mg/12,5 mg tabletter er hvide eller næsten hvide, 6,55 x 13,6 mm ovale og bikonvekse tabletter mærket med "TH" på den ene side. 
Actelsar HCT 40 mg/12.5 mg tablets are white or almost white, 6.55 x 13.6 mm oval-shaped and biconvex tablets marked with “TH” on one side.
Sådan skal du tage Actelsar HCT 
How to take Actelsar HCT
Actelsar HCT findes ligeledes med dosisstyrke 80 mg/ 25 mg 
Actelsar HCT is also available at the dose strength 80 mg/25 mg
Som alternativ anbefales behandlingsregimer med bedre etablerede sikkerhedsprofiler ved amning, specielt ved amning af nyfødte og præmature spædbørn.- 
Because no information is available regarding the use of telmisartan during breast-feeding, Actelsar HCT is not recommended and alternative treatments with better established safety profiles during breast-feeding are preferable, especially while nursing a newborn or preterm infant.
MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE Pap til HDPE tabletbeholder 
PARTICULARS TO APPEAR ON THE OUTER PACKAGING Carton for HDPE tablet container
Aplastisk anæmi, hæmolytisk anæmi, knoglemarvssvigt, leukopeni, neutropeni, agranulocytose 
Aplastic anaemia, haemolytic anaemia, bone marrow failure, leukopenia, neutropenia, agranulocytosis
Actelsar HCT 80 mg/25 mg tabletter 
Actelsar HCT 80 mg/25 mg tablets
Actelsar HCT 80 mg/25 mg tabletter er hvide eller næsten hvide, 9,0 x 17,0 mm ovale og bikonvekse tabletter mærket med “TH” på den ene side og “25” på den anden side. 
Actelsar HCT 80 mg/25 mg tablets are white or almost white, 9.0 x 17.0 mm oval-shaped and biconvex tablets marked with “TH” on one side and “25” on the other side.
Alvorligt angioødem kan forekomme i sjældne tilfælde (≥1/10.000 til <1/1.000). 
(≥1/10,000 to <1/1,000).
Følgende bivirkninger af ukendt hyppighed er rapporteret ved brug af hydrochlorthiazid alene: Infektioner og parasitære sygdomme 
Adverse reactions of unknown frequency reported with the use of hydrochlorothiazide alone include:
- Medicin, der kan forhøje indholdet af kalium i blodet, såsom vanddrivende medicin, kaliumtilskud, saltsubstitutter som indeholder kalium og ACE-hæmmere (blodtrykssænkende medicin), ciclosporin ((undertrykker kroppens immunforsvar) og andre lægemidler såsom heparinnatrium (blodfortyndende medicin). 
- Medicines that may increase blood potassium levels such as potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium, ACE inhibitors, cyclosporin (an immunosuppressant drug) and other medicinal products such as heparin sodium (an anticoagulant).
Reykjavikurvegur 78 220 Hafnarfjörður ISLAND 
Reykjavikurvegur 78 220 Hafnarfjörður Iceland
Thiazider kan øge risikoen for bivirkninger ved behandling med amantadin. 
Thiazides may increase the risk of adverse events caused by amantadine.
Actelsar HCT 40 mg/12,5 mg tabletter Én tablet indeholder 40 mg telmisartan og 12,5 mg hydrochlorthiazid. 
Actelsar HCT 40 mg/12.5 mg tablets Each tablet contains 40 mg telmisartan and 12.5 mg hydrochlorothiazide.
Nedsat kaliumindhold i blodet, angst, besvimelse, snurrende, prikkende og stikkende fornemmelse (paræstesi), følelse af at dreje rundt (svimmelhed), hjertebanken (takykardi), forstyrret hjerterytme, lavt blodtryk, et pludseligt fald i blodtrykket, når du rejser dig op, stakåndethed (dyspnø), diaré, mundtørhed, luftafgang fra tarmen, rygsmerter, muskeltrækninger, muskelsmerter, erektil dysfunktion (manglende evne til at få eller opretholde erektion), brystsmerter, forhøjet urinsyreindhold i blodet. 
Decreased blood potassium levels, anxiety, fainting (syncope), sensation of tingling, pins and needles (paraesthesia), feeling of spinning (vertigo), fast heart beat (tachycardia), heart rhythm disorders, low blood pressure, a sudden fall in blood pressure when you stand up, shortness of breath (dyspnoea), diarrhoea, dry mouth, flatulence, back pain, muscle spasm, muscle pain, erectile dysfunction (inability to get or keep an erection), chest pain, increased blood uric acid levels.
- Medicin til behandling af diabetes (insulin eller orale lægemidler såsom metformin) - Colestyramin og colestipol, medicin til at sænke blodets fedtindhold. 
- Cholestyramine and colestipol, medicines for lowering blood fat levels.
Lungebetændelse (bronkitis), provokation eller forværring af systemisk lupus erythematosus (en sygdom, hvor kroppens immunsystem angriber kroppen, hvilket forårsager ledsmerter, hududslæt og feber); ondt i halsen, bihulebetændelse, tristhed (depression), besvær med at falde i søvn (insomni), forringet syn, besvær med at trække vejret, mavesmerter, forstoppelse, oppustethed (dyspepsi), utilpashed (opkastning), mavekatar, unormal leverfunktion (japanske patienter har større sandsynlighed for at få denne bivirkning), rødme af huden, allergiske reaktioner såsom kløe eller udslæt, øget svedproduktion, nældefeber (urticaria), ledsmerter (artralgi) og smerter i arme og ben, muskelkramper, influenzalignende symptomer, smerter. 
Inflammation of the lungs (bronchitis), activation or worsening of systemic lupus erythematosus (a disease where the body's immune system attacks the body, which causes joint pain, skin rashes and fever); sore throat, inflamed sinuses, feeling sad (depression), difficulty falling asleep (insomnia), impaired vision, difficulty breathing, abdominal pain, constipation, bloating (dyspepsia), feeling sick (vomiting), inflammation of the stomach (gastritis), abnormal liver function (Japanese patients are more likely to experience this side effect), redness of the skin (erythema), allergic reactions such as itching or rash, increased sweating, hives (urticaria), joint pain (arthralgia) and pain in extremities, muscle cramps, flu-like-illness, pain, low levels of sodium, increased levels of creatinine, hepatic enzymes or creatine phosphokinase in the blood.
Stort forbrug af hydrochlorthiazid (≥ 50.000 mg kumulativt) var forbundet med en justeret OR-værdi på 1,29 (95 %-KI: 1,23-1,35) for basalcellekarcinom og på 3,98 (95 %-KI: 3,68-4,31) for pladecellekarcinom. 
High HCTZ use (≥50,000 mg cumulative) was associated with an adjusted OR of 1.29 (95% CI: 1.23
Reykjavíkurvegur 76-78, 220 Hafnarfjörður, Island 
Reykjavíkurvegur 76-78, 220 Hafnarfjörður, Iceland
Actelsar HCT 80 mg/12,5 mg tabletter Én tablet indeholder 80 mg telmisartan og 12,5 mg hydrochlorthiazid. 
Actelsar HCT 80 mg/12.5 mg tablets Each tablet contains 80 mg telmisartan and 12.5 mg hydrochlorothiazide.
Actelsar HCT 80 mg/12,5 mg tabletter er hvide eller næsten hvide, 9,0 x 17,0 mm kapselformede tabletter mærket med “TH 12.5” på begge sider. 
Actelsar HCT 80 mg/12.5 mg tablets are white or almost white, 9.0 x 17.0 mm capsule-shaped tablets marked with “TH 12.5” on both sides.
Somnolens Luftveje, thorax og mediastinum Ikke almindelig: 
Respiratory, thoracic and mediastinal disorders Uncommon:
Knogler, led, muskler og bindevæv Ikke kendt: 
Musculoskeletal, connective tissue and bone disorders Not known:
Hypokaliæmi kan ved samtidig brug af digitalisglykosider eller visse antiarytmika resultere i muskelkramper og/eller accentueret arytmi. 
Hypokalaemia may result in muscle spasms and/or accentuate arrhythmia associated with the concomitant use of digitalis glycosides or certain anti-arrhythmic medicinal products.
Actelsar HCT 40 mg/12,5 mg tabletter 
Actelsar HCT 40 mg/12.5 mg tablets
Det kan være andre vanddrivende tabletter (diuretika), afføringsmidler (f.eks. amerikansk olie), kortikosteroider (f.eks.prednison), ACTH (et hormon), amphotericin (mod svampeinfektion), carbenoxolen (til at behandle mundsår), benzylpenicillin (et antibiotikum) og salicylsyre og hermed beslægtede stoffer. 
- Medicines associated with low blood potassium (hypokalaemia) such as other diuretics, (“water tablets”), laxatives (e.g. castor oil), corticosteroids (e.g. prednisone), ACTH (a hormone), amphotericin (an antifungal medicine), carbenoxolone (used to treat mouth ulcers), penicillin G sodium (an antibiotic), and salicylic acid and derivatives.
Reykjavíkurvegur 78, 220 Hafnarfjörður, Island 
Reykjavíkurvegur 78, 220 Hafnarfjörður, Iceland
Pankreatit, gastrointestinalt ubehag 
Pancreatitis, stomach discomfort
Sepsis* (ofte kaldet "blodforgiftning"), en alvorlig infektion med betændelsesreaktion i hele kroppen, hurtig hævelse af hud og slimhinder (angioødem), blærer og afskalning af det øverste lag af huden (toksisk epidermal nekrolyse). 
Sepsis* (often called “blood poisoning”), is a severe infection with whole-body inflammatory response, rapid swelling of the skin and mucosa (angioedema); blistering and peeling of the top layer of skin (toxic epidermal necrolysis) these side effects are rare (may affect up to 1 in 1,000 people) or of unknown frequency (toxic epidermal necrolysis) but are extremely serious and patients should stop taking the medicine and see their doctor immediately.
28 tabletter 56 tabletter 84 tabletter 90 tabletter 98 tabletter 
28 tablets 56 tablets 84 tablets 90 tablets 98 tablets
14 tabletter 28 tabletter 30 tabletter 56 tabletter 84 tabletter 90 tabletter 98 tabletter 
14 tablets 28 tablets 30 tablets 56 tablets 84 tablets 90 tablets 98 tablets
Der er dog kun rapporteret om minimal eller ingen påvirkning ved den mængde thiazid (12,5 mg), som findes i Actelsar HCT. 
An increase in cholesterol and triglyceride levels has been associated with thiazide diuretic therapy; however, at the 12.5 mg dose contained in Actelsar HCT, minimal or no effects were reported.
Der er ikke blevet udført andre prækliniske forsøg med fastdosiskombinationsproduktet 80 mg/25 mg. I tidligere prækliniske sikkerhedsforsøg med samtidig indgift af telmisartan og hydrochlorthiazid i normotensive rotter og hunde i doser, der gav en eksponering sammenlignelig med den i det kliniskterapeutiske område, fandt man ikke andre resultater end dem, der allerede var set ved indgift af de to stoffer hver for sig. 
Previous preclinical safety studies performed with co-administration of telmisartan and hydrochlorothiazide in normotensive rats and dogs, in doses producing exposure comparable to that in the clinical therapeutic range, caused no additional findings not already observed with administration of either substance alone.
14 tabletter 28 tabletter 56 tabletter 84 tabletter 90 tabletter 98 tabletter 
14 tablets 28 tablets 56 tablets 84 tablets 90 tablets 98 tablets